Новости | Магазин | Журналы | Контакты | Правила | Доставка | |
Вход Регистрация |
В статье рассматриваются последние достижения лучевой диагностики при обследовании пациенток с предполагаемым раком молочной железы на различных этапах диагностики. Описываются возможности двухэнергетической контрастной спектральной маммографии, магнитно-резонансной томографии в первичной диагностике заболевания и при оценке распространенности процесса, вовлеченности контралатеральной молочной железы, обсуждаются оптимальная методика проведения исследования и принципы интерпретации полученных данных в ежедневной практике.
Ключевые слова:
рак молочной железы, диагностика, двухэнергетическая контрастная спектральная маммография, магнитно-резонансная томография, breast cancer, diagnostics, dual-energy contrast spectral mammography, magnetic resonance imaging
Литература:
1.Lewin J.M., Isaacs P.K., Vance V., Larke F.J. Dual-energy contrast-enhanced digital subtraction mammography: feasibility. Radiology. 2003; 229 (1): 261-268. http://doi.org/10.1148/radiol.2291021276
2.Dromain C., Thibault F., Muller S. et al. Dual-energy contrast-enhan ced digital mammography: initial clinical results. Eur. Radiol. 2011; 21 (3): 565-574. http://doi.org/10.1007/s00330-010-1944-y
3.Jochelson M.S., Dershaw D.D., Sung J.S. et al. Bilateral contrast-enhanced dual-energy digital mammo graphy: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology. 2013; 266 (3): 743-751. http://doi.org/10.1148/radiol.12121084
4.Daniaux M., De Zordo T., Santner W. et al. Dual-energy contrast-enhanced spectral mammography (CESM). Arch. Gynecol. Obstet. 2015; 292 (4): 739-747. http://doi.org/10.1007/s00404-015-3693-2
5.Cheung Y.C., Lin Y.C., Wan Y.L. et al. Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis. Eur. Radiol. 2014; 24 (10): 2394-2403. http://doi.org/10.1007/s00330-014-3271-1
6.Fallenberg E.M., Dromain C., Diekmann F. et al. Contrastenhanced spectral mammo graphy versus MRI: Initial results in the detection of breast cancer and assessment of tumour size. Eur. Radiol. 2014; 24 (1): 256-264. http://doi.org/10.1007/s00330-013-3007-7
7.Lobbes M.B., Lalji U., Houwers J. et al. Contrast-enhanced spectral mammo graphy in patients referred from the breast cancer screening programme. Eur. Radiol. 2014; 24 (7): 1668-1676. http://doi.org/10.1007/s00330-014-3154-5
8.Wernli K.J., DeMartini W.B., Ichikawa L. et al.; Breast Cancer Surveillance Consortium. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern. Med. 2014; 174 (1): 125-132. http://doi.org/10.1001/jamainternmed.2013.11963
9.Cott Chubiz J.E., Lee J.M., Gilmore M.E. et al. Costeffectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers. Cancer. 2013; 119 (6): 1266-1276. http://doi.org/10.1002/cncr.27864
10.Kuhl C.K., Schrading S., Strobel K. et al. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2014; 32 (22): 2304-2310. http://doi.org/10.1200/JCO.2013.52.5386
11.Luczynska E., Heinze-Paluchowska S., Hendrick E. et al. Comparison between breast MRI and contrast-enhanced spectral mammography. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2015; 21: 1358-1367. http://doi.org/10.12659/MSM.893018
12.Helal M.H., Mansour S.M., Ahmed H.A. et al. The role of contrast-enhanced spectral mammography in the evaluation of the postoperative breast cancer. Clin Radiol. 2019; 74 (10): 771-781. http://doi.org/10.1016/j.crad.2019.06.002
13.Hobbs M.M., Taylor D.B., Buzynski S., Peake R.E. Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance. J. Med. Imaging Radiat. Oncol. 2015; 59 (3): 300-305. http://doi.org/10.1111/1754-9485.12296
14.Оксанчук Е.А., Колесник А.Ю., Меских Е.В. Контрастная маммография в дифференциальной диагностике заболеваний молочных желез: первые результаты. Res. Pract. Med. J. 2017; S2: 73.
15.Okada N., Tatsugami F., Sugai M. et al. The feasibility of contrast-enhanced spectral mammography immediately after contrast-enhanced CT. Radiol. Phys. Technol. 2019; 12 (3): 277-282. http://doi.org/10.1007/s12194-019-00518-6
16.La Forgia D., Catino A., Dentamaro R. et al. Role of the contrast-enhanced spectral mammography for the diagnosis of breast metastases from extramammary neoplasms. J. BUON Off. J. Balk. Union Oncol. 2019; 24 (4): 1360-1366.
17.Belli P., Costantini M., Romani M. et al. Magnetic resonance imaging in breast cancer recurrence. Breast Cancer Res. Treat. 2002; 73 (3): 223-235. http://doi.org/10.1023/a:1015868406986
18.Fanizzi A., Losurdo L., Basile T.M.A. et al. Fully Automated Support System for Diagnosis of Breast Cancer in Contrast-Enhanced Spectral Mammography Images. J. Clin. Med. 2019; 8 (6): E891. http://doi.org/10.3390/jcm8060891
The article discusses the latest achievements of radiation diagnostics in the examination of patients with suspected breast cancer at various stages. The possibilities of dual-energy contrast spectral mammography, magnetic resonance imaging in the primary diagnosis of the disease and in assessing the prevalence of the process, the involvement of the contralateral breast, the optimal methodology of the study and the principles of interpretation of the data obtained in daily practice are discussed.
Keywords:
рак молочной железы, диагностика, двухэнергетическая контрастная спектральная маммография, магнитно-резонансная томография, breast cancer, diagnostics, dual-energy contrast spectral mammography, magnetic resonance imaging